Compare courses
Harvard Medical School

Infectious Diseases in Adults

This course has no confirmed dates in the future. Check out relevant courses from other schools.

Relevant courses

Course format
Max price
Starting after
Ending before


Infectious Diseases in Adults provides important updates and state-of-the-art approaches for the prevention, diagnosis and management of infectious diseases: common, challenging, rare and emerging. This highly rated course focuses on major clinical syndromes as well as management controversies. It features a range of case-based, interactive, and problem-solving sessions from master clinicians in the field. Topics with major impact on clinical practice are emphasized. This includes infections of national and international importance. The course provides education that ensures attendees are current with recent developments in the prevention and management of infections, including the newer antibacterial, antiviral and antiparasitic agents. Preventive treatments including vaccines and prophylaxis

Learning Objectives

Upon completion of this course, participants will be able to:

  • Draw upon increased knowledge and clinical skills in Infectious Diseases
  • Utilize the latest strategies for the prevention, recognition, diagnosis, and treatment of important syndromes in Infectious Diseases
  • Determine a differential diagnosis and initiate an appropriate diagnostic evaluation for the major infectious disease-related problems in outpatient and inpatient clinical practice
  • Better analyze and translate areas of basic and clinical science relevant to the field

State-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases

This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven:

  • State-of-the-art approaches to common infections
  • New strategies for treating highly resistant bacterial infections
  • Clinical approaches to complex, rare, "don't-miss" infections
  • New and emerging infectious diseases
  • Update on antifungal diagnostics and therapy
  • Optimal management of Staph aureus
  • Infections in persons with substance use disorders
  • What’s new in HIV management
  • Hep C treatment workshop
  • Live New England Journal of Medicine Clinicopathologic Conference (CPC)
  • Musculoskeletal infectious diseases

As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.


Expanded Case-Based and Problem-Solving Education

The 2019 program features an expanded range of interactive, case-based and problem-solving education. The formats are engaging and attendees are encouraged to pose questions in larger sessions as well as one-on-one with the national experts who will be providing updates at this event.

Treating Highly Resistant Bacterial Infections, including:

  • MRSA and vancomycin-intermediate Staph aureus (VISA)
  • Extended spectrum beta-lactamase (ESBL)-producing gram negative rods
  • Carbapenemase-producing gram negative rods, including the NDM-1 metallo-beta-lactamase-producing organisms
  • Vancomycin-resistant enterococci (VRE)
  • Azole-resistant fungal infections

Common Infectious Diseases: Updates in Prevention, Diagnosis and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:

  • Infections in immunocompromised hosts
  • Infections in pregnancy, including Zika
  • Infections in persons with substance use disorders
  • Infections of travelers
  • Systemic fungal infections
  • Native and device-related orthopedic infections
  • Ear, nose and throat (ENT) and eye infections
  • Bronchiectasis and pneumonia
  • Native and device-related central nervous system (CNS) infections
  • HIV and its infectious and noninfectious complications
  • PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
  • Sexually transmitted infections
  • Hepatitis C monoinfection and coinfection
  • Tick and mosquito-borne infections and zoonoses
  • Vaccination
  • Clostridium difficile infection

Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:

  • Zika, Ebola, Middle Eastern Respiratory Syndrome (MERS), and other emerging infectious diseases
  • Re-emergence of vaccine-preventable diseases
  • Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium chimaera
  • Candida auris infection
  • Infections in travelers and immigrants
  • Zoonoses—the old and the new

Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

  • Selecting the right antimicrobial
  • Utilizing newer diagnostic tests
  • Diagnosing low-probability but high-impact infections
  • Rapidly detecting life-threatening infections
  • Determining when and how long to hospitalize in the treatment of infectious diseases
  • The outpatient transition: IV or oral?
  • Optimizing empiric antimicrobial therapy: what to start, when to narrow or when to stop

Our talks and workshops incorporate safety, quality and practice improvement in infectious diseases, including:

  • Antimicrobial stewardship workshop (optional)
  • Infection control
  • Early inpatient ID consultations to reduce mortality, length of stay, and cost
  • Outpatient Parenteral Antibiotic Therapy (OPAT): best practices in program design and operation
  • ID for hospital medicine practitioners


In 2019, we offer two optional pre-course workshops, giving you the option of in-depth, small-group learning about important topics in ID.

Please note: Seating is limited, and each workshop is available on a first-come, first-served basis.

State-of-the-Art Treatment of Hepatitis C Virus (HCV) Monday, April 22, 3:30 - 5:30 pm

HCV disease management continues to rapidly advance. This special program provides small group, interactive, intensive and practical education for clinicians who wish to provide care for HCV-infected patients.

Highlights include:

  • Screening and testing for HCV infection, and staging of liver disease for the non-hepatologist
  • A comprehensive, targeted review of the treatment options for patients with HCV infection according to their HCV genotype, treatment experience and disease stage
  • Best practices for patient assessment, treatment, monitoring, side-effect management, and HCV care after cure (follow-up and cancer screening)
  • Evolving strategies for management of HCV and HIV coinfection
  • Guidance for managing persons with HCV and substance use disorders

Participants will leave with specific recommendations to improve the clinical care of people infected with HCV.

Principles and Practices for an Antimicrobial Stewardship Program (ASP)

Monday, April 22, 3:30 - 5:30 pm

This special workshop provides evidence-based principles and strategies to:

  • Build the necessary infrastructure and implement aneffective ASP
  • Comply with the CDC’s seven core elements for hospital ASPs
  • Utilize and integrate the microbiology lab and pharmacy into a multidisciplinary ASP
  • Identify the ways in which antimicrobial stewardship leads to improved outcomes, including:
    • Lower antimicrobial costs
    • Decreased incidence of resistant bacterial and candidal infections
    • Ensured optimal antimicrobial dosing, administration and monitoring
  • Utilize national benchmarking data to judge program outcomes and success
  • Measure the impacts and improve the outcomes of stewardship interventions
  • Create training programs for ASP practitioners (physicians, physician extenders, nurses and pharmacists) in your institution
  • Recognize the role of rapid diagnostics with ASP oversight and interpretation


Day 1

1:30pm to 3:30pm Registration

Optional Pre-Course Workshops Moderator: Dr. Nesli Basgoz

PLEASE NOTE: Seating is limited, and each workshop is available on a first-come, first-served basis.

3:30pm to 5:30pm State-of-the-Art Treatment of Hepatitis C Virus (HCV) Arthur Kim, MD and Susanna Naggie, MD, MHS

Full description of hepatitis C workshop

3:30pm to 5:30pm State-of-the-Art Principles and Practices for an Antimicrobial Stewardship Program (ASP) Alyssa R. Letourneau, MD, MPH

Full description of antimicrobial stewardship workshop

Course Registration

6:00pm to 8:00pm Registration

Tuesday, April 23, 2019 Main Course: Infectious Diseases in Adults

6:30am to 7:45am Registration and Continental Breakfast

7:45am to 8:05am Introduction and Road Map Nesli Basgoz, MD

Morning Session / Moderator: Dr. Nesli Basgoz

8:05am to 8:50am Major Antimicrobial Classes: The New Fundamentals Alyssa R. Letourneau, MD, MPH

8:50am to 8:55am Q & A Session

8:55am to 9:45am New Antibiotics: Expanded Treatment Options for Resistant Infections David C. Hooper, MD

9:45am to 9:50am Q & A Session

9:50am to 10:25am The Cost of Our Drugs: Branded, Generic and Why We Should Care Rochelle P. Walensky, MD, MPH

10:25am to 10:30am Q & A Session

10:30am to 10:50am Coffee Break

Refreshments provided

10:50am to 11:40am Current Approaches to Infection Control Erica S. Shenoy, MD, PhD

11:40am to 11:45am Q & A Session

11:45am to 12:30pm Update on Antifungal Diagnostics and Therapy Michael Mansour, MD, PhD

12:30pm to 12:35pm Q & A Session

12:35pm to 1:50pm Break for lunch*

Afternoon Session / Moderator: Dr. Nesli Basgoz

1:50pm to 2:40pm Staphylococcus aureus: Déjà Vu All Over Again Henry F. Chambers, MD

2:40pm to 2:45pm Q & A Session

2:45pm to 3:25pm Advances in Treating Hepatitis C Monoinfection Arthur Kim, MD

3:25pm to 3:30pm Q & A Session

3:30pm to 3:50pm Coffee Break Refreshments provided

3:50pm to 4:50pm Encephalitis and Healthcare-Associated CNS Infections: Guidelines and Best Practices Allan R. Tunkel, MD, PhD, MACP

4:50pm to 4:55pm Q & A Session

Day 2

6:30am to 8:00am Continental Breakfast Served

Concurrent Breakfast Breakouts

7:00am to 8:00am 1. ID Updates for the Hospital Medicine Specialist Miriam B. Barshak, MD

  1. OPAT for ID Specialists Kevin L. Ard, MD, MPH

Morning Session / Moderator: Dr. Sandra B.Nelson

8:00am to 8:55am Skin and Soft Tissue Infections: Optimized Diagnostic and Treatment Approaches Sandra B. Nelson, MD

8:55am to 9:00am Q & A Session

9:00am to 9:50am Eye and ENT Infections: What You Need to Know Miriam B. Barshak, MD

9:50am to 9:55am Q & A Session

9:55am to 10:15am Coffee Break Refreshments provided

10:15am to 11:00am Urinary Tract Infections: The Common and the Complicated Sigal Yawetz, MD

11:00am to 11:05am Q & A Session

11:05am to 11:50am Infections in Persons with Substance Use Disorder: New Horizons and Emerging Approaches Jennifer A. Johnson, MD

11:50am to 11:55am Q & A Session

11:55am to 1:10pm Break for lunch*
Afternoon Session / Moderator: Dr. Rajesh T. Gandhi

1:10pm to 1:55pm Curbside Consults and E-Consults Paul E. Sax, MD

1:55pm to 2:00pm Q & A Session

2:00pm to 2:50pm Endocarditis: Updates and Controversies Molly L. Paras, MD

2:50pm to 2:55pm Q & A Session

2:55pm to 3:15pm Coffee Break Refreshments provided

3:15pm to 4:00pm Clinical Advances from the Microbiology Laboratory Sarah E. Turbett, MD

4:00pm to 4:05pm Q & A Session

4:05pm to 5:00pm My Most Difficult Cases Course Directors

5:00pm to 5:15pm Q & A Session

Day 3

6:30am to 8:00am Continental Breakfast Served
Breakfast Breakout

7:00am to 8:10am Conference on Retroviruses and Opportunistic Infections (CROI): 2019 Updates Nesli Basgoz, MD, Rajesh T. Gandhi, MD, Virginia Triant, MD, MPH and Kevin L. Ard, MD, MPH

8:10am to 8:15am Q & A Session
Morning Session / Moderator: Dr. Rajesh T. Gandhi

8:15am to 9:10am HIV Management in 2019 Rajesh T. Gandhi, MD

9:10am to 9:15am Q & A Session

9:15am to 10:05am Continuing Challenges in HIV-Associated Opportunistic Infections Nesli Basgoz, MD

10:05am to 10:10am Q & A Session

10:10am to 10:30am Coffee Break

Refreshments provided

10:30am to 11:05am Pre- and Post-Exposure Prophylaxis for HIV Kevin L. Ard, MD, MPH

11:05am to 11:10am Q & A Session

11:10am to 12:10pm Live: New England Journal of Medicine Clinicopathologic Conference (CPC) Eric S. Rosenberg, MD

12:10pm to 12:15pm Q & A Session

12:15pm to 1:30pm Break for lunch*

Afternoon Session / Moderator: Dr. Nesli Basgoz

1:30pm to 2:00pm Checkpoint Inhibitors and CAR-T Cell Therapy for the ID Clinician Michael Mansour, MD, PhD

2:00pm to 2:05pm Q & A Session

2:05pm to 3:10pm Infections in Hematologic Malignancies and Stem Cell Transplantation Sarah Hammond, MD

3:10pm to 3:15pm Q & A Session

3:15pm to 3:35pm Coffee Break Refreshments provided

3:35pm to 4:40pm Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy Camille Nelson Kotton, MD

4:40pm to 4:45pm Q & A Session

4:45pm to 5:30pm Flummoxing Cases in Fungal Diseases Michael Mansour, MD, PhD and Sarah E. Turbett, MD

5:30pm to 5:35pm Q & A Session

5:45pm to 7:30pm Reception for all course particpants and faculty Join us for refreshments and to meet your faculty and colleagues

Day 4

6:30am to 8:00am Continental Breakfast Served
Breakfast Breakout

7:00am to 7:55am Breakout Session: Challenging Cases in Highly Resistant Bacterial Infections Alyssa R. Letourneau, MD, MPH and Ramy Elshaboury, PharmD, BCPS-AQ ID

7:55am to 8:00am Q & A Session
Morning Session / Moderator: Dr. Sandra B. Nelson

8:00am to 8:40am Native Bone and Joint Infections: Age-Old Problems and New Challenges Sandra B. Nelson, MD

8:40am to 8:45am Q & A Session

8:45am to 9:35am Tropical Medicine and Parasitology Edward T. Ryan, MD

9:35am to 9:40am Q & A Session

9:40am to 10:00am Coffee Break Edward T. Ryan, MD

10:00am to 10:50am Travel Medicine and Immunizations: 2019 Updates

10:50am to 10:55am Q & A Session Refreshments provided

10:55am to 11:35am Orthopedic Device Infections Sandra B. Nelson, MD

11:35am to 11:40am Q & A Session

11:40am to 12:55pm Break for lunch*

Afternoon Session / Moderator: Dr. Nesli Basgoz

12:55pm to 1:55pm Bronchiectasis and Pneumonia: Putting It All Together: Clinical, Radiographic, and Microbiologic Nesli Basgoz, MD

1:55pm to 2:00pm Q & A Session

2:00pm to 2:55pm Tuberculosis Update 2019 Rocío Hurtado, MD, DTM&H

2:55pm to 3:00pm Q & A Session

3:00pm to 3:45pm Nontuberculous Mycobacteria Nesli Basgoz, MD

3:45pm to 3:50pm Q & A Session

3:50pm to 4:10pm Coffee Break

Refreshments provided

4:10pm to 5:00pm Tick Talk: Expert Guidance for Lyme and Other Tick-Borne Illnesses Kimon C. Zachary, MD

5:00pm to 5:05pm Q & A Session

5:05pm to 6:00pm Sexually Transmitted Infections

Donna Felsenstein, MD

6:00pm to 6:05pm Q & A Session

Day 5

6:30am to 8:00am Continental Breakfast Served

Morning Session / Moderator: Dr. Nesli Basgoz

8:00am to 8:40am ID Images: A Digital Library for Learning Infectious Diseases Rajesh T. Gandhi, MD

8:40am to 8:45am Q & A Session

8:45am to 9:35am New and Emerging Viruses Martin S. Hirsch, MD

9:35am to 9:40am Q & A Session

9:40am to 10:25am Infections in Pregnancy (including Zika) Andrea Ciaranello, MD

10:25am to 10:30am Q & A Session

10:30am to 11:25am Zoonoses Jane E. Koehler, MD

11:25am to 11:30am Q & A Session

11:30am to 12:10pm Clostridium difficile Infection, including Recurrent and Refractory Disease and Novel Approaches Elizabeth Hohmann, MD

12:10pm to 12:15pm Q & A Session

Who should attend

PHYSICIANS, NPs, PAs, PHARMACISTS in the fields of:

  • Infectious Diseases
  • Hospital Medicine
  • Internal Medicine
  • Family Practice
  • Pulmonary and Critical Care Medicine
  • Emergency Medicine ...and others who care for, diagnose, and treat patients with infectious diseases
Show more


Dr. Azar obtained his medical degree from the American University of Beirut in Lebanon. He then completed a post-doctoral research fellowship at Yale followed by Internal Medicine Residency at Indiana University. He is trained in both Infectious Diseases (Yale) and Clinical Microbiology (Massachu...
Area of Special Interest Antimicrobial drug resistance, staphylococcal infections, experimental therapeutics and epidemiology and pathogenesis of disease caused by community-acquired methicillin-resistant Staphylococcus aureus. Professional Recognitions & Appointments Co-Chair - IDSA guid...


Detailed Description
Detailed Description